Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Email Format
{first_name}.{last_name}@numab.com — 50.0%
sarah.smith@numab.com
{first_letter_first_name}.{last_name}@numab.com — 50.0%
s.smith@numab.com
Key Employees
Contact details of 6 Numab executives
David Urech
1 Emails
0 Phones
-
Work email
d*****h@numab.com
-
Personal email
davidurech2174@gmail.com
Other Employees
Contact details of 1 Numab other employees
U003ed Urech
1 Emails
0 Phones
-
Work email
u**********h@numab.com
General Emails
General company emails, e.g. customer support lines
info@numab.com
General Inquiries
admin@numab.com
Admin Team
legal@numab.com
Legal Department
o.middendorp@numab.com
Unclassified inbox
dataprotection@numab.com
Unclassified inbox
Similar Companies like Numab
HQ: North Chicago, Illinois, United States
AbbVie
AbbVie is a pharmaceutical company that discovers, develops,...
HQ: North Chicago, Illinois, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,
Legal Name: AbbVie Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active
HQ: New York, New York, United States
Pfizer Venture Investments
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,
Legal Name: Pfizer Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
HQ: Rahway, New Jersey, United States
Merck
Merck is a biopharmaceutical company that offers medicines a...
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,
Legal Name: Merck & Co., Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
Company Info
Last updated: 27/07/2025
41445330471
Wadenswil, Zurich, Switzerland
Numab General Information
Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.